Stockreport

Goldman Sachs Raises GoodRx (GDRX) Price Target, Keeps Neutral Rating [Yahoo! Finance]

GoodRx Holdings, Inc. - Class A  (GDRX) 
PDF increased its price target on GoodRx Holdings, Inc. (NASDAQ:GDRX) from $3.75 to $4 and kept a Neutral rating. This decision came after the company reported its results [Read more]